Guizhen Wu to Immunization Schedule
This is a "connection" page, showing publications Guizhen Wu has written about Immunization Schedule.
Connection Strength
0.032
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
Score: 0.032